UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium tuberculosis

Antimicrobial agents and chemotherapy, 2014-05, Vol.58 (5), p.2979-2981

2014

Volltextzugriff (PDF)

In Vitro Combination Studies of Benzothiazinone Lead Compound BTZ043 against Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy, 2012-11, Vol.56 (11), p.5790-5793

2012

Volltextzugriff (PDF)

Towards a new combination therapy for tuberculosis with next generation benzothiazinones

EMBO molecular medicine, 2014-03, Vol.6 (3), p.372-383

2014

Volltextzugriff (PDF)

Accelerated microfluidic native chemical ligation at difficult amino acids toward cyclic peptides

Nature communications, 2018-07, Vol.9 (1), p.2847-12, Article 2847

2018

Volltextzugriff (PDF)

Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumps

Nature communications, 2022-01, Vol.13 (1), p.115-115, Article 115

2022

Volltextzugriff (PDF)

A druggable secretory protein maturase of Toxoplasma essential for invasion and egress

eLife, 2017-09, Vol.6

2017

Volltextzugriff (PDF)

Streptomycin-Starved Mycobacterium tuberculosis 18b, a Drug Discovery Tool for Latent Tuberculosis

Antimicrobial Agents and Chemotherapy, 2012-11, Vol.56 (11), p.5782-5789

2012

Volltextzugriff (PDF)

Simple Model for Testing Drugs against Nonreplicating Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy, 2010-10, Vol.54 (10), p.4150-4158

2010

Volltextzugriff (PDF)

Assessing the essentiality of the decaprenyl‐phospho‐d‐arabinofuranose pathway in Mycobacterium tuberculosis using conditional mutants

Molecular microbiology, 2014-04, Vol.92 (1), p.194-211

2014

Volltextzugriff (PDF)

Update on the Discovery of Efflux Pump Inhibitors against Critical Priority Gram-Negative Bacteria

Antibiotics (Basel), 2023-01, Vol.12 (1), p.180

2023

Volltextzugriff (PDF)

Regioselective and Stereoselective Synthesis of Parthenolide Analogs by Acyl Nitroso-Ene Reaction and Their Biological Evaluation against Mycobacterium tuberculosis

International journal of molecular sciences, 2023-12, Vol.24 (24), p.17395

2023

Volltextzugriff (PDF)

Towards a new tuberculosis drug: pyridomycin – nature's isoniazid

EMBO molecular medicine, 2012-10, Vol.4 (10), p.1032-1042

2012

Volltextzugriff (PDF)

Intragenic Distribution of IS6110 in Clinical Mycobacterium tuberculosis Strains: Bioinformatic Evidence for Gene Disruption Leading to Underdiagnosed Antibiotic Resistance

Microbiology spectrum, 2021-09, Vol.9 (1), p.e0001921-e0001921

2021

Volltextzugriff (PDF)

Anticytolytic Screen Identifies Inhibitors of Mycobacterial Virulence Protein Secretion

Cell host & microbe, 2014-10, Vol.16 (4), p.538-548

2014

Volltextzugriff (PDF)

HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms

Pharmacogenetics and genomics, 2010-02, Vol.20 (2), p.112-120

2010

Volltextzugriff (PDF)

Characterization of new, efficient Mycobacterium tuberculosis topoisomerase-I inhibitors and their interaction with human ABC multidrug transporters

PloS one, 2018-09, Vol.13 (9), p.e0202749

2018

Volltextzugriff (PDF)

Genome-Wide Definition of the SigF Regulon in Mycobacterium tuberculosis

Journal of Bacteriology, 2012-04, Vol.194 (8), p.2001-2009

2012

Volltextzugriff (PDF)

A Novel Natural Siderophore Antibiotic Conjugate Reveals a Chemical Approach to Macromolecule Coupling

ACS central science, 2023-11, Vol.9 (11), p.2138-2149

2023

Volltextzugriff (PDF)

Micrococcin P1 – A bactericidal thiopeptide active against Mycobacterium tuberculosis

Tuberculosis (Edinburgh, Scotland), 2016-09, Vol.100, p.95-101

2016

Volltextzugriff (PDF)

Dactylosporolides: Glycosylated Macrolides from Dactylosporangium fulvum

Journal of natural products (Washington, D.C.), 2022-12, Vol.85 (12), p.2714-2722

2022

Volltextzugriff (PDF)

Discovery and Biosynthesis of Gladiolin: A Burkholderia gladioli Antibiotic with Promising Activity against Mycobacterium tuberculosis

Journal of the American Chemical Society, 2017-06, Vol.139 (23), p.7974-7981

2017

Volltextzugriff (PDF)

Optimization of pyridylpiperazine-based inhibitors of the Escherichia coli AcrAB-TolC efflux pump

European journal of medicinal chemistry, 2023-11, Vol.259, p.115630-115630, Article 115630

2023

Volltextzugriff (PDF)

Synthesis and Antimycobacterial Activity of 2,1′-Dihydropyridomycins

ACS medicinal chemistry letters, 2013-02, Vol.4 (2), p.264-268

2013

Volltextzugriff (PDF)

Tricyclic SpiroLactams Kill Mycobacteria In Vitro and In Vivo by Inhibiting Type II NADH Dehydrogenases

Journal of medicinal chemistry, 2022-12, Vol.65 (24), p.16651-16664

2022

Volltextzugriff (PDF)

Synthesis and Structure–Activity Relationship Studies of C2-Modified Analogs of the Antimycobacterial Natural Product Pyridomycin

Journal of medicinal chemistry, 2020-02, Vol.63 (3), p.1105-1131

2020

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(56)

Sprache

Englisch
(55)
Russisch
(1)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium tuberculosis

In Vitro Combination Studies of Benzothiazinone Lead Compound BTZ043 against Mycobacterium tuberculosis

Towards a new combination therapy for tuberculosis with next generation benzothiazinones

Accelerated microfluidic native chemical ligation at difficult amino acids toward cyclic peptides

Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumps

A druggable secretory protein maturase of Toxoplasma essential for invasion and egress

Streptomycin-Starved Mycobacterium tuberculosis 18b, a Drug Discovery Tool for Latent Tuberculosis

Simple Model for Testing Drugs against Nonreplicating Mycobacterium tuberculosis

Assessing the essentiality of the decaprenyl‐phospho‐d‐arabinofuranose pathway in Mycobacterium tuberculosis using conditional mutants

Update on the Discovery of Efflux Pump Inhibitors against Critical Priority Gram-Negative Bacteria

Regioselective and Stereoselective Synthesis of Parthenolide Analogs by Acyl Nitroso-Ene Reaction and Their Biological Evaluation against Mycobacterium tuberculosis

Towards a new tuberculosis drug: pyridomycin – nature's isoniazid

Intragenic Distribution of IS6110 in Clinical Mycobacterium tuberculosis Strains: Bioinformatic Evidence for Gene Disruption Leading to Underdiagnosed Antibiotic Resistance

Anticytolytic Screen Identifies Inhibitors of Mycobacterial Virulence Protein Secretion

HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms

Characterization of new, efficient Mycobacterium tuberculosis topoisomerase-I inhibitors and their interaction with human ABC multidrug transporters

Genome-Wide Definition of the SigF Regulon in Mycobacterium tuberculosis

A Novel Natural Siderophore Antibiotic Conjugate Reveals a Chemical Approach to Macromolecule Coupling

Micrococcin P1 – A bactericidal thiopeptide active against Mycobacterium tuberculosis

Dactylosporolides: Glycosylated Macrolides from Dactylosporangium fulvum

Discovery and Biosynthesis of Gladiolin: A Burkholderia gladioli Antibiotic with Promising Activity against Mycobacterium tuberculosis

Optimization of pyridylpiperazine-based inhibitors of the Escherichia coli AcrAB-TolC efflux pump

Synthesis and Antimycobacterial Activity of 2,1′-Dihydropyridomycins

Tricyclic SpiroLactams Kill Mycobacteria In Vitro and In Vivo by Inhibiting Type II NADH Dehydrogenases

Synthesis and Structure–Activity Relationship Studies of C2-Modified Analogs of the Antimycobacterial Natural Product Pyridomycin

Suchergebnisse filtern